Literature DB >> 11398959

Preferences about the characteristics of future HIV prevention products among men who have sex with men.

M Rader1, G Marks, G Mansergh, N Crepaz, L C Miller, P R Appleby, S Murphy.   

Abstract

This study of men who have sex with men (MSM) examined preferences about the characteristics of a potential product for preventing sexual transmission of HIV, such as a rectal microbicide. MSM were recruited in West Hollywood, California. They self-administered a questionnaire and rated 48 product characteristics representing seven dimensions. Overall, the ratings were highest for effectiveness in preventing HIV and other sexually transmitted diseases, followed by characteristics reflecting the physical or secondary effects of the product and logistics of use. Physical attributes, convenience/accessibility, and psychological aspects had intermediate ratings; interpersonal dynamics had the lowest rating. Men with negative attitudes about using condoms to prevent HIV infection were more likely than their counterparts to prefer a product that does not reduce sexual sensation or pleasure, does not break the mood, and can be used after a sexual encounter ends. A similar pattern was observed when participants were stratified by whether or not they had engaged in unprotected anal intercourse in the past 12 months. The findings inform the development, testing, and marketing of a future HIV prevention product for MSM.

Entities:  

Mesh:

Year:  2001        PMID: 11398959     DOI: 10.1521/aeap.13.2.149.19735

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  7 in total

1.  The second wave will drown us.

Authors:  Michael Gross
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

Review 2.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

Review 3.  Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies.

Authors:  Lisa A Eaton; Seth Kalichman
Journal:  Curr HIV/AIDS Rep       Date:  2007-12       Impact factor: 5.071

4.  An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study.

Authors:  Margaret A Chesney; Beryl A Koblin; Patrick J Barresi; Marla J Husnik; Connie L Celum; Grant Colfax; Kenneth Mayer; David McKirnan; Franklyn N Judson; Yijian Huang; Thomas J Coates
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

5.  Hypothetical Rectal Microbicide Acceptability and Factors Influencing It among Men Who Have Sex with Men in Tianjin, China.

Authors:  Guohong Zhang; Huifang Zhang; Hongxuyang Yu; Zheng Zhao; Jie Yang; Mianzhi Zhang; Minying Zhang
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

6.  Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.

Authors:  Gordon Mansergh; Krishna Kiran Kota; Rob Stephenson; Sabina Hirshfield; Patrick Sullivan
Journal:  J Int AIDS Soc       Date:  2021-01       Impact factor: 6.707

7.  Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men.

Authors:  Ana Ventuneac; Alex Carballo-Diéguez; Ian McGowan; Robert Dennis; Amy Adler; Elena Khanukhova; Charles Price; Terry Saunders; Chomchay Siboliban; Peter Anton
Journal:  AIDS Behav       Date:  2009-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.